5 FDA decisions to watch in the third quarter
BioPharma
Source: biopharmadive.com
📰 Iveric Zimura News
Iveric Zimura News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iveric Zimura. Real-time updates on events, politics, business and more.
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
Astellas Pharma agreed to acquire Iveric Bio for approximately $5.9 billion, in a deal designed to expand the buyer’s eye treatment pipeline.
Source: genengnews.com